Catalyst Wire Dossier Catalyst Wire Dossier

JOURNAVX

SUZETRIGINE · Vertex Pharmaceuticals Incorporated
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JOURNAVX, covering 2025-01-30 to 2026-01-23. Get the full timeline:

Most recent: FDA Approved: JOURNAVX — Supplemental Application (Vertex Pharmaceuticals Incorporated)

See pricing